IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response

Clinical Rheumatology

Volumn 35, Issue 9, 2016, Pages 2251-2258

  Zeng, Mei ^a   Dang, Wantai ^a   Chen, Baofeng ^a   Qing, Yufeng ^a   Xie, Wenguang ^a   Zhao, Mingcai ^a   Zhou, Jingguo ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Acute gouty arthritis; IL 37; MSU crystals; Spontaneous resolution

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 37; INTERLEUKIN 6; INTERLEUKIN 7; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; URATE; IL37 PROTEIN, HUMAN; INTERLEUKIN 1; URIC ACID;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; GOUT; HUMAN; HUMAN CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SUPERNATANT; BLOOD; GENETICS; METABOLISM; MONONUCLEAR CELL; REMISSION;

ARTHRITIS, GOUTY; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; MIDDLE AGED; REMISSION, SPONTANEOUS; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; URIC ACID;

EID: 84946761239     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-015-3109-5     Document Type: Article

References (31)

1. Martinon F, Glimcher LH (2006) Gout: new insights into an old disease. J Clin Invest 116:2073–2075
2. Weaver AL (2008) Epidemiology of gout. Cleve Clin J Med 75:S9–S12
3. Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859–1864
4. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 67:960–966
5. Taniguchi A, Kammatani N (2008) Control of renal uric acid excretion and gout. Curr Opin Rheumatol 20:192–197
6. Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521
7. Ghaemi-Oskouie F, Shi Y (2011) The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep 13:160–166
8. Cronstein BN, Terkeltaub R (2006) The inflammatory process of gout and its treatment. Arthritis Res Ther 8:S1–S3
9. Ortiz-Bravo E, Sieck MS, Schumacher HR Jr (1993) Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 36:1274–1285
10. Lioté F, Prudhommeaux F, Schiltz C, Champy R, Herbelin A, Ortiz-Bravo E et al (1996) Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1. Arthritis Rheum 39:1192–1198
11. Falasca GF, Ramachandrula A, Kelley KA, O’Connor CR, Reginato AJ (1993) Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 36:105–116
12. Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL-1) as a mediator of crystal arthritis: stimulation of T cell and synovial fi broblast mitogenesis by urate crystalinduced IL-1. J Immunol 138(10):3213–3218
13. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M (1989) Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 83:585–592
14. Guerne PA, Terkeltaub R, Zuraw B, Lotz M (1989) Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32:1443–1452
15. Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T (1989) Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 169:291–296
16. Chen YH, Hsieh SC, Chen WY, Li KJ, Wu CH, Wu PC et al (2011) Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFβ1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3. Ann Rheum Dis 70:1655–1663
17. Anna S, Francesca O, Roberta R, Frallonardo P, Dayer JM, Punzi L (2012) Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase. Ann Rheum Dis 71:621–624
18. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014–1022
19. Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117:3720–3732
20. Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D et al (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22:127–147
21. Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S et al (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18:61–71
22. Sharma S, Kulk N, Nold MF, Graf R, Kim SH, Reinhardt D et al (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180:5477–5482
23. Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA (2004) Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 381:503–510
24. McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB et al (2011) Interleukin 37 expression protects mice from colitis. PNAS 108(40):16711–16716
25. Ballak DB, van Diepen JA, Moschen AR, Jansen HJ, Hijmans A, Groenhof GJ et al (2014) IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun 5:4711
26. Moretti S, Bozza S, Oikonomou V, Renga G, Casagrande A, Lannitti RG et al (2014) IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis. Plos Pathog 10(11), e1004462
27. Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y et al (2014) IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 12:69
28. Zhao PW, Jiang WG, Wang L (2014) Plasma levels of IL-37 and correlation with TNF-a, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 9, e95346
29. Scanu A, Oliviero F, Gruaz L, Sfriso P, Pozzuoli A, Frezzato F et al (2010) High-density lipoproteins down-regulate CCL2 production in human fibroblast like synoviocytes stimulated by urate crystals. Arthritis Res Ther 12:R23
30. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241
31. Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO (2004) Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 50:2273–2280